ESC Professional Premium Access

Mavacamten induces a clinical, hemodynamic, and biomarker response beyond the primary endpoint in EXPLORER-HCM: results from a post hoc machine learning analysis

Congress Session

About the speaker

Professor Iacopo Olivotto

Careggi University Hospital (AOUC), Florence (Italy)
12 presentations

4 more presentations in this session

Metoprolol improves left ventricular longitudinal function at rest and during exercise in obstructive hypertrophic cardiomyopathy

Speaker: Mrs A. Dybro (Aarhus, DK)


Prevalence and clinical correlates of clinical red flags for rare diseases in consecutive patients presenting with HCM phenotype

Speaker: Doctor N. Maurizi (Florence, IT)


Temporal trends, characteristics and comorbidities of patients with hypertrophic cardiomyopathy in denmark from 2005-2018: A nationwide cohort study.

Speaker: Doctor C. Zoerner (Copenhagen, DK)


Representativeness of EXPLORER-HCM trial and prevalence of eligibility criteria for Mavacamten in a nationwide cohort

Speaker: Doctor M. Brandao (Vila Nova de Gaia, PT)


Access the full session

Hypertrophic cardiomyopathy: not so rare, but not so easy

Speakers: Professor I. Olivotto, Mrs A. Dybro, Doctor N. Maurizi, Doctor C. Zoerner, Doctor M. Brandao

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk